SUMMARY-To determine the degree to which host immunity is responsible for papilloma regression, 3-methylcholanthrene-treated allografts were placed on maximally immunodepressed recipients (thymectomy + 450 R radiation and weekly antithymocyte serum injections). Almost 80% of the papillomas on the allografts regressed. Cellular or humoral immune capacity in the recipient animals could not be detected by conventional means. Therefore, the regressions were probably the result of a nonimmunologic mechanism. The data showed that more papillomas regressed on multiples of 21 ± 4 days, from the day of grafting, than in the intervening periods. This clustering pattern of regressions was not observed in immunocompetent animals. In competent mice, two or more mechanisms, one of which is immunity, may contribute to the regression of chemically induced skin papillomas.-J Nat Cancer Inst 47: 653-665, 1971.
SINCE MANY inadequacies of host immunity as a surveillance mechanism against tumors have been found (1, 2) , this work was done to examine critically the degree to which immunity is effective in one experimental system. The skin papilloma model as described by Lappe (3) was chosen because: 1) Several authors have suggested that papilloma regressions aTe mediated by an immune response (3) (4) (5) ; 2) the graft promotion model of Lappe yields relatively large numbers of papillomas in a short time without the use of chemical promoters (6) ; 3) the papillomas were antigenic and responded biologically to altered host immunity (3) . To determine whether immunity was an effective mediator of papilloma regression, it was decided to totally remove the immune response and to follow the pattern of regressions, if they occurred. This was achieved by a severe and prolonged immunosuppressive regimen. Rather than the classical isograft system as originally described by Lappe (3), carcinogen-treated allografts were used as monitors of the degree of immunosuppression.
MA TERIALS AND METHODS
Animals.-All mice were bred and maintained at The Institute for Cancer Research in Philadelphia. Isogeneity was periodically monitored by reciprocal skin grafting. The animals were housed 6 per stainless-steel cage, fed Purina Laboratory Chow, and in most experiments given, ad libitum, water supplemented with Terramycin (Chas. Pfizer & Co., New York, N.Y.). The strains were BALB/cAnN (BALB/c), C57BL/6JN (C57BL), and C3H/HeN (C3H).
Carcinogen.-The polycyclic hydrocarbon, 3-methylcholanthrene (MCA) (Eastman Organic Chemicals, Rochester, N.Y.), was used. A standard 10% concentration was prepared by melting 1 g MCA crystals with 9 g Paraplast (Tissue Embedding Medium, Sherwood, St. Louis, Mo.) in a beeswax bath. Strips of 0.45-tL Millipore filter (Millipore Corp., Bedford, Mass.), 2 X 15 cm, were dipped into the mixture once and allowed to harden. The resulting strips of 10% MCA were then cut into rectangles 2 X 3 cm containing approximately 8 mg carcinogen.
Treatment and preparation of skin-graft donors.-
On anesthetized animals the lateral thoracic skin was shaved and covered with a thin layer of vaseline and a rectangle of carcinogen-impregnated filter was applied. The filters were then secured with a strip of Air Vent Tape (Johnson & Johnson, New Brunswick, N.J.). Ten days after application, tapes and carcinogen-impregnated filters were removed under light anesthesia. The animals then rested 5 days. On the day of grafting, donors were killed by cervical dislocation. Split-thickness grafts were prepared as described by Billingham (7). The skin was reflected and all underlying fat, muscle, and fascia were scraped off with a blunt scalpel. The prepared skin was placed, raw side down, on #1 Whatman filter paper, and a 13-mm diameter graft was punched out with a #9 cork borer. Individual grafts were kept on salinemoistened filter paper in petri dishes and stored in a refrigerator between preparation and grafting.
Skin grafting of recipients.-Split-thickness graft beds were prepared, as described by Thoenes (8) , on the right lateral thorax. A dusting of Terramycin-Polymyxin B powder (Chas. Pfizer & Co.) was applied to the raw graft bed and on the graft surface. The graft was then covered with a square of vaseline gauze (Adaptic Non-Adhering Dressing, Johnson & Johnson) and secured with Air Vent Tape. Tapes were removed from the grafts after 11 or 12 days. The grafts were examined daily for 1 or 2 weeks, then thrice weekly. Any raised lesion within the graft margins which appeared on 2 or more consecutive readings was considered a papilloma and was drawn twice its actual size in a 2-cm circle depicting the graft area. Each reading was blind with respect to the time elapsed since grafting and to the previously recorded status of the graft.
Immunodepression of reC£pients.-Animals under Nembutal anesthesia, were thymectomized through a midsternal incision by suction.
Irradiation.-Plexiglass wheels with separate compartments for 18 mice contained animals for irradiation. The unit was a General Electric Maxitron 250-III therapy unit generating 250 kv at 15 rna. The target source distance was 60 cm and the filters were 0.5 mm Cu and 1 mm AI. Animals received 450 roentgens at the rate of approximately 60/minute. The wheels were rotated on a turntable under the source to insure constant and equal exposure.
Antithymocyte serum preparation and administration.-Rabbit antimouse thymocyte serum (ATS) was prepared by the method of Davis et al. (9) . Usually 10 domestic white rabbits were given injections of 400-500 million C57BL male thymocytes emulsified in an equal amount of complete Freund's adjuvant (Difco, Detroit, Mich.). Suspensions were adjusted so that 1 cc contained the proper number of cells. Rabbits were lightly anesthetized and given injections of 0.5 cc of the mixture in each hind footpad. One month later they received intravenously an equal number of cells prepared in 1 cc Hanks' balanced salt solution. One week after the second injection, the animals were exsanguinated by cardiac puncture and the blood was refrigerated. The serum was extracted and pooled, and 1 : 10,000 Merthiolate was added. Each 100 cc serum was then added to 3 cc of washed, packed, mouse erythrocytes and incubated at 4°C for 15 minutes. After this absorption, all serum was sterilized by CO 2 pressure through a 0. each batch of ATS was tested for immunosuppressive potency by evaluation of graft survival times in a weak H-2 incompatible system (DBA/2 on BALB/c <;l<;l). Administration of the serum was by subcutaneous injection of 0.25 cc the day before grafting and on days 1, 3, 5, and 7 after grafting, unless otherwise stated.
Experiments.-The experimental design is shown in text-figure 1. Two series were conducted; the isograft control group described was used only in the second series.
In the first series, 35 BALB/c female mice, 6 weeks old, were treated with 10% MCA rectangles for 10 days. Five days after removal of the tapes and carcinogen, the treated skin was prepared and grafted to C3H females, 8 weeks old. These animals had been immunodepressed by the combined regimen of thymectomy, 450 R irradiation, and ATS as described earlier. The animals were maintained weekly on the ATS for the duration of the experiment.
In the second series, 46 C3H recipients were immunodepressed as above. Thirty-four received BALB/c allografts treated as above. The remaining 12 animals, however, received C3H female isografts obtained from 5-week-old mice that had been treated with paraffin rectangles for 10 days. All mice received ATS weekly until termination of the series. In both series, tapes were removed from the grafts after 12 days and the grafts were read daily for 1 week, then 3 times weekly.
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Skin and Graft to: Table 1 gives the combined data for all tumors. Although 35 animals were initially used in series one, 17 died before papillomas arose and 2 died while bearing papillomas. The severity of the combined immunosuppressive regimen was fully appreciated at this time. The surviving animals were quite debilitated for several months, after which they appeared healthier. These factors may have accounted for the low papilloma incidence seen in the first series (50%). The last animal in this series died 236 days after grafting; it still had a papilloma it had borne for 222 days. The papilloma incidences obtained in both series agree with those of Lappe using comparably treated animals. The values are those expected for directly treated grafts on severely immunodepressed mice. The most striking results presented in table 1 concern the regressions. An average of 80% of the papillomas from both series regressed, despite the fact that the allografts remained healthy and in place. Figures  1-3 show a typical papilloma from inception through regression, a slow and gradual process. Diagrammatically this is shown in text-figure 2 which depicts the course of tumors on a number of grafts. Some tumors waxed and waned as their longevity increased. Most, however, increased to a certain size, maintained it for an interval, then gradually decreased and disappeared. Histologic sections of established tumors, tumors in apparent
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TEXT-FIGURE I.-Experimental design of grafting procedure. MeA-treated allografts were placed on maximally depressed recipients.
10 Days 6 ). Lappe referred to these as "fingerprints" of papilloma regression. In the 2 series reported, no carcinomas were found. Table I shows that the SEM for the duration values was extremely high, an indication of great variation in individual papilloma longevity. From this, one might think that the regressions occurred at random. When, however, the days on which papillomas regressed were plotted, regardless of their individual duration, the regressions were not random. In fact, the data suggested that the papillomas regressed in clusters, roughly at 21-day intervals from the day of grafting. To determine if regressions were occurring in clusters, the data were analyzed statistically. First, the 21st day and multiples thereof were used as intervals. Next, limits were assigned to the intervals, ± 4 days. This evened the numbers of observations around a particular interval. To consider the full potential of the population to regress, a regression percentage was calculated for each day of observation. This was a calculation of the numbers of papillomas regressing among the total population at risk for that particular day. The "at risk" value was important because it changed daily as members left or joined the total population. Papillomas were not considered at risk on the day they arose but were so considered on the next observation. The regression percentage data for this series are indicated in text-figure 3. Note the propensity of papillomas to regress within the shaded areas, denoting 21 ± 4 days from the day of grafting. These intervals are hereafter referred to as active intervals. The periods between active intervals are referred to as intervening periods. Each day of observation and its respective regression percentage were then examined by the nonparametric Mann-Whitney U test (10) .
----' ---
Although all calculations gave a U value, the z value was also computed to obtain an exact probability level (table 2) . The nonsignificant value obtained in series I (P>O.2) is due entirely to one regression percentage point, 33.33%, occurring on day 68 (text- fig. 3 ). This point lies just outside an active interval. Despite these results, a second series was carried out to confirm that regressions were occurring in clusters at 21-day intervals. The results of the second series were striking. As seen in table 2, there were almost equal numbers of regression percentage values for comparison, and the difference is significant at the 2% level. The series-l data combined with the series-2 data have an overall probability at the 3% level.
Although a greater percentage of regressions occurred during active intervals than intervening periods, the question arose as to the percentage of fig. 3 ), the rate of regression was the same from one active interval to another. This suggests that whatever caused the regressions, it was a homogeneous influence in pulses or waves centering around multiples of 21 days from the time of grafting. To determine if the cyclic regressions observed in the 2 series would occur in competent animals, the regression data of papillomas on 35 normal BALB/c females were evaluated. The ani- 
P<0.397).

Evaluation of Immunosuppression
The allograft model was used as a monitor of immunosuppression. Despite this, it was necessary to exclude the possibility that either residual immunity was present or the immune capacity of the animals had returned during the experiment. Because the animals from the 2 series were examined somewhat differently, they will be described separately. Fifteen animals were chosen at random and had their original MCA allografts removed 64 days after grafting. After 1 week, they were regrafted on the opposite (left) side from the original allograft with normal (untreated) BALB/c female skin obtained from 6-week-old mice. As the size of an allograft has been shown to significantly affect its survival time (11, 12) these secondary allografts were only 8 mm in diameter to allow even a weak immunity a chance to manifest itself. The ATS treatment was continued weekly. Because there were 100% takes of the miniature grafts, the ATS treatment was discontinued 14 days after the second grafting. The animals had received a total of 15 doses (0.25 cc each) over 85 days. Table 4 lists the grafting procedures and their relationship in time to the original allograft and the A TS treatments. On all mice, the second BALB/c allografts lasted 70 days or more after the last ATS injection ( fig. 7) .
Recipients From Series 2
The 12 C3H mice given paraffin-treated isografts rather than MCA-treated allografts (text- fig. 1 ) served as controls to determine if the allograft recipients could be immunized while undergoing the immunosuppressive regimen. The sequence of grafting procedures is shown in table 5. The ATS treatment was stopped in 12 randomly chosen animals, and the 12 isograft controls and all grafts were excised. After resting for 1 week, all mice received an 8-mm secondary allograft of normal BALB/c female skin obtained from 6-weekold animals.
Two mice died after the second grafting. Of the remaining 22 grafts, only 3 were rejected. Two were on animals originally with allografts; the third was on an animal bearing an isograft. (A comparison of 2 rejections of 11 grafts vs. 1 of 11 gives a x 2 = 0.00 with a Yates correction, df 1;
P>0.90.)
These results would be expected to have occurred by chance alone almost 100% of the time.
Evaluation of Humoral Immunity
Although the grafting procedures could detect cell-mediated immunity, they could not be used to detect humoral immunity. To investigate antibodyforming capability, 5 and 6 animals were chosen from series 1 and 2 respectively. In addition, 3 normal C3H mice were added as controls. All the animals were given a 0.2-cc intraperitoneal injection of washed sheep erythrocytes [sheep red blood cells (rbc)] (Colorado Serum Co., Denver, Colo.). Twelve days after injection, the mice were bled and their sera were harvested separately. The Cooke Microtitrator system was used to run duplicate twofold dilutions of individual sera (0.025 ml). Washed, saline-diluted sheep rbc (1/100) were added to each dilution (0.025 ml). The plates were covered and incubated for 1 hour at 37°C. The titer was read as the reciprocal of the highest dilution displaying hemagglutination. All mice from both series were negative (had no detectable titer); the 3 normal control mice gave titers> 1: 1024.
DISCUSSION
Evidence presented by other investigators firmly establishes that immunity contributes to the pathogenesis of papillomas (3, 4, 13) . Lappe concluded that all regressions were probably mediated by an immune mechanism in response to the individual papilloma's tumor-specific transplantation antigens. I t has been suggested that the word "rejection" be more fitting than regression (6) . The experiments reported here have shown that about 80% of papillomas regressed in the apparent absence of an immune response. The significance of these findings rests on the assumption that immunity had, in fact, been abolished in these animals. It cannot be claimed that every vestige of immune responsiveness had been removed; our present means of detection are not adequate to sense extremely low levels. Thus, one could always argue that weak, undetectable levels of immunity were present in the allograft recipients and that the papillomas were far more sensitive to this immunity than were the allografts. While I cannot eliminate the argument of residual or returning competence, I have attempted to exclude these possibili ties.
The fact that animals could maintain second allografts for 70 days after the last ATS treatment strongly suggests a severe impairment of cellular immune responsiveness. Inability to produce hemagglutinins in response to sheep rbc does not completely exclude the possibility that other antibody may have been produced. It suggests, however, suppression of antibody-forming capability.
Even if we conceded that some competence was present, other observations argue against an immune mechanism being responsible for all regressions. Lymphoid infiltrates were conspicuously absent in numerous sections taken from depressed animals with tumors in all stages of growth and regression. This is in sharp contrast to the characteristic infiltrates associated with immune regressions (3, 4) (cJ. figs. 4, 6 ).
From the results obtained in these attempts to demonstrate immunity, it is concluded that the animals were completely immunosuppressed, within the limits of present detection, when their papillomas regressed. Thus the regressions were probably mediated by a mechanism other than immunity.
Despite the results discussed, we have data indicating that immunity can mediate some regressions. This implies then that more than one mechanism can result in regressions. Kreider and associates have recently discussed the possibility of a dual mechanism in tumor pathogenesis. Using Shope papilloma virus to produce papillomas in fetal rat skin chips, they found that papilloma survival is increased by immunosuppression. The normal low incidence of papillomas, 7-10%, is not increased, however, by immunosuppression (13) . These results suggest that a mechanism, other than immunity, is responsible for the initial low incidence.
If 2 or more mechanisms are present, I of which is immunity, then the cyclic regressions observed in the 2 series are probably the result of the other, nonimmune, mechanism. Regression data in competent animals should not show any cyclic pattern.
(If both mechanisms are working together, immune regressions, which occur at random, should obliterate the cyclic pattern.) This theory was examined by evaluating the regression data in the normal BALB/c females. The failure to detect cycling in these mice suggests that both mechanisms (immune and nonimmune) are operational in competent animals.
The cyclic regression findings are different from reports of other investigators in several respects. Della Porta et al. (14) and Stenback (15), using a continual promotional stimulus, reported constant addition of new tumors while others were regressing.
In these situations, the main conclusion was that regressions paralleled tumor inception rather closely, the former occurring approximately 21 days after the latter. In the present studies, most papillomas occurred all at once as a result of the graft promotion and therefore they became a fixed population from which members regressed, but to which very few were added (90% of the total population was present by the 25th day after grafting). There was not, therefore, a constant promotional stimulus, as in the other studies. The 2l-day figure for regressions was also seen in this study. The difference, however, was that all the regressions did not occur on the 21st day after appearance of the tumor but rather in multiples of 21 days.
The mechanism of nonimmune regressions, while vague, has at least one hallmark: a cyclic pattern. The pattern, however, is somewhat of an artifact. The regressions are really not occurring within the 21 ± 4 days; they just physically disappear in those periods. In reality, the tumors may start regressing 2 or 3 intervals before they actually disappear. This is evidenced by their gradual decrease in size before final disappearance (see text-fig. 2 ). Anyone of several mechanisms could fit this pattern.
One possible mechanism is the hair-follicle cycle. Other investigators have suggested a relationship between the hair cycle and regression (16, 17) . Since grafting is known to induce a new cycle (18) and G 1 would be expected at about 21 days, this pattern fits the first active interval observed. There is, however, no correlation with subsequent intervals, because hair-follicle cycles in grafted skin do not occur at regular 2l-day intervals (19) .
Yet another mechanism that cannot be discarded is a chalone-type effect. Bullough has shown cyclic fluctuations of chalone level associated with wound healing (20). It is not unrealistic then to consider a graft as a large wound with an abundance of new cells. Since the normal lifespan of an epidermal cell is about 21 days, one might expect local fluctuations of chalone concentration in the graft at approximately 2l-day intervals. To postulate, however, that such fluctuations would result in regressions is another matter (21) .
A final mechanism to consider is that of an intrinsic mechanism stopping cell division. Such a mechanism is proposed by Hayflick and Moorhead who state that tumor cells are probably immortal, while normal cells have a fixed number of genertions (22). Since papillomas are considered premalignant tumors, they probably retain many characteristics of the normal tissue from which they arise.
Since these studies were on female animals, there is a possibility, albeit remote, that the peculiar cycling results from some hormonal fluctuation. The pattern must therefore be demonstrated in males.
While the mechanisms have not been defined, this study has revealed non immune mechanisms capable of producing papilloma regressions. 
